JNJ

J&J acquires 3D-printed spinal implant maker EIT
J&J acquires 3D-printed spinal implant maker EIT
Mass Device
JNJ
devices
spinal fusion
Emerging Implant Technologies
EIT
M&A
Flag link:
Johnson & Johnson raises a flag in early-stage lung cancer with first-ever contest in the field
Johnson & Johnson raises a flag in early-stage lung cancer with first-ever contest in the field
Fierce Pharma
JNJ
innovation
R&D
lung cancer
drug development
Flag link:
Ph III Trial Shows Improved Outcomes with Tremfya after Failure With Humira
Ph III Trial Shows Improved Outcomes with Tremfya after Failure With Humira
CP Wire
Janssen Pharmaceuticals
JNJ
chronic plaque psoriasis
Tremfya
Humira
AbbVie
clinical trials
Flag link:
Ph III Trial Shows Improved Outcomes with Tremfya after Failure With Humira
Janssen Pharmaceuticals
JNJ
chronic plaque psoriasis
Tremfya
Humira
Flag link:
India Orders Payments From J&J’s DePuy Over ‘Faulty’ Hip Implants
India Orders Payments From J&J’s DePuy Over ‘Faulty’ Hip Implants
RAPS.org
India
DePuy
JNJ
hip implants
Flag link:
Amarin Corporation, CRISPR Therapeutics, and Geron Corporation could all see big gains next week
Amarin Corporation, CRISPR Therapeutics, and Geron Corporation could all see big gains next week
Motley Fool
Amarin
CRISPR Therapeutics
Geron
Vascepa
Vertex Pharmaceuticals
CTX001
JNJ
imetelstat
Flag link:
Ketamine is emerging as a popular treatment for depression. New research suggests the drug acts like an opioid
Ketamine is emerging as a popular treatment for depression. New research suggests the drug acts like an opioid
CNBC
depression
ketamine
opioids
JNJ
Allergan
Flag link:
ESC 2018 – J&J not downhearted after Xarelto stumbles
ESC 2018 – J&J not downhearted after Xarelto stumbles
EP Vantage
ESC 2018
JNJ
Xarelto
bloodthinner
Flag link:
Johnson & Johnson Is Hiring -- and It's Ginormous News for Geron
Johnson & Johnson Is Hiring -- and It's Ginormous News for Geron
Yahoo/Motley Fool
JNJ
Geron
hirings
imetelstat
Imbruvica
Flag link:
ESC 2018 – Xarelto again fails to Command an advantage
ESC 2018 – Xarelto again fails to Command an advantage
EP Vantage
JNJ
Bayer
Xarelto
ESC 2018
Flag link:
Jumping ahead of AstraZeneca, AbbVie and J&J get a green light to market Imbruvica/Rituxan combo for rare lymphoma
Jumping ahead of AstraZeneca, AbbVie and J&J get a green light to market Imbruvica/Rituxan combo for rare lymphoma
Endpoints
AbbVie
JNJ
FDA
Imbruvica
Rituxan
Roche
AstraZeneca
non-Hodgkin's lymphoma
Waldenström’s macroglobulinemia
Flag link:
Pfizer lawsuit could clear path for biosimilars
Pfizer lawsuit could clear path for biosimilars
Medical Marketing and Media
Pfizer
JNJ
Remicade
biosimilars
Inflectra
Flag link:
Janssen, Lundbeck and Takeda Raise Issues With FDA Draft Guidance on MDD Drugs
Janssen, Lundbeck and Takeda Raise Issues With FDA Draft Guidance on MDD Drugs
RAPS.org
FDA
JNJ
Janssen
Lundbeck
Takeda
major depressive disorder
drug development
Flag link:
Should Gilead Be Worried About This New Monthly HIV Medication?
Should Gilead Be Worried About This New Monthly HIV Medication?
Motley Fool
Gilead Sciences
HIV
JNJ
ViiV
cabotegravir
rilpivirine
Edurant
Flag link:
Judge Denies J&J Motion to Dismiss Pfizer Lawsuit Over Remicade
Judge Denies J&J Motion to Dismiss Pfizer Lawsuit Over Remicade
RAPS.org
Pfizer
JNJ
Remicade
biosimilars
Inflectra
Flag link:
Drug firms fight US government’s Iraq corruption probe
Drug firms fight US government’s Iraq corruption probe
Pharmaforum
Iraq
DOJ
AstraZeneca
Roche
JNJ
GE
Pfizer
Flag link:
Pharma watchers on Twitter chat up Johnson & Johnson Xarelto TV ad that seems 'misleading'
Pharma watchers on Twitter chat up Johnson & Johnson Xarelto TV ad that seems 'misleading'
Fierce Pharma
JNJ
Xarelto
drug ads
twitter
social media
Flag link:
Johnson & Johnson CEO Alex Gorsky dines with Trump as president promises ‘substantial’ drug price cuts
Johnson & Johnson CEO Alex Gorsky dines with Trump as president promises ‘substantial’ drug price cuts
Fierce Pharma
JNJ
Pharma CEOs
Alex Gorsky
Donald Trump
drug pricing
Flag link:
Pfizer Wins Remicade Patent Case Over J&J
Pfizer Wins Remicade Patent Case Over J&J
RAPS.org
Pfizer
Celltrion
JNJ
Janssen
patents
Remicade
Flag link:
BMS, Pfizer's fast-growing Eliquis is about to steamroll market-leader warfarin: executive
BMS, Pfizer's fast-growing Eliquis is about to steamroll market-leader warfarin: executive
Fierce Pharma
Pfizer
Bristol-Myers Squibb
JNJ
Eliquis
Xarelto
Warfarin
bloodthinners
Flag link:

Pages